You are here » Home » Companies » Company Overview » Glaxosmithkline Pharma Ltd

Glaxosmithkline Pharma Ltd.

BSE: 500660 Sector: Health care
NSE: GLAXO ISIN Code: INE159A01016
BSE LIVE 15:59 | 09 Dec 2746.90 14.30
(0.52%)
OPEN

2716.65

HIGH

2760.00

LOW

2716.65

NSE LIVE 15:45 | 09 Dec 2738.05 -1.40
(-0.05%)
OPEN

2725.00

HIGH

2774.40

LOW

2725.00

OPEN 2716.65
PREVIOUS CLOSE 2732.60
VOLUME 1031
52-Week high 3850.00
52-Week low 2600.00
P/E 67.11
Mkt Cap.(Rs cr) 23266.24
Buy Price 0.00
Buy Qty 0.00
Sell Price 2746.90
Sell Qty 41.00
OPEN 2716.65
CLOSE 2732.60
VOLUME 1031
52-Week high 3850.00
52-Week low 2600.00
P/E 67.11
Mkt Cap.(Rs cr) 23266.24
Buy Price 0.00
Buy Qty 0.00
Sell Price 2746.90
Sell Qty 41.00

About Glaxosmithkline Pharma Ltd.

Glaxosmithkline Pharma Ltd

GlaxoSmithKline Pharma Ltd is one of the world's leading research-based pharmaceutical and healthcare companies. The company's product portfolio includes prescription medicines and vaccines. Their prescription medicines range across therapeutic areas such as anti-infectives dermatology gynaecology diabetes oncology cardiovascular disease and respiratory diseases. They also offer a range of vaccine...> More

Glaxosmithkline Pharma Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   23,266
EPS - TTM () [*S] 40.93
P/E Ratio (X) [*S] 67.11
Face Value ()   10
Latest Dividend (%)   500.00
Latest Dividend Date 15 Jul 2016
Dividend Yield (%) 1.82
Book Value / Share () [*S] 219.95
P/B Ratio () [*S] 12.49
[*C] Consolidated     [*S] Standalone

Glaxosmithkline Pharma Ltd - Financial Results

Particulars ( cr) Sep 2016 Sep 2015 % Chg
Net Sales 799.12 717.53 11.37
Other Income 18.24 31.34 -41.8
Total Income 817.36 748.87 9.15
Total Expenses 658.38 597.27 10.23
Operating Profit 158.98 151.6 4.87
Net Profit 98.85 95.55 3.45
Equity Capital 84.7 84.7 -
> More on Glaxosmithkline Pharma Ltd Financials Results

Glaxosmithkline Pharma Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Divi's Lab. 1160.65 -0.15 30809.45
Piramal Enterp. 1721.35 -0.63 29701.89
Glenmark Pharma. 904.10 1.50 25513.70
Glaxosmit Pharma 2746.90 0.52 23266.24
Torrent Pharma. 1341.90 0.05 22707.63
Alkem Lab 1675.30 -0.21 20028.21
Biocon 943.25 2.25 18865.00
> More on Glaxosmithkline Pharma Ltd Peer Group

Glaxosmithkline Pharma Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 75.00
Banks/FIs 8.20
FIIs 2.08
Insurance 0.00
Mutual Funds 1.71
Indian Public 11.93
Custodians 0.00
Other 1.08
> More on Glaxosmithkline Pharma Ltd Share Holding Pattern

Glaxosmithkline Pharma Ltd - Research Reports

Date Broker Action Price Report
02/11 Angel Broking Neutral 3295 PDF IconDetails
06/08 Angel Broking Neutral 3746 PDF IconDetails
> More on Glaxosmithkline Pharma Ltd Research Reports

Glaxosmithkline Pharma Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week 1.16% 0.61% 1.97% 2.16%
1 Month 3.40% 3.15% -1.85% -2.02%
3 Month -8.22% -8.76% -7.12% -6.82%
6 Month -21.32% -21.87% -0.06% 0.71%
1 Year -15.60% -16.27% 6.83% 8.53%
3 Year 9.24% 9.05% 25.42% 29.82%

Glaxosmithkline Pharma Ltd - STOCK STRENGTH

Today's Low/High 2716.65
2760.00
Week Low/High 2670.00
2785.00
Month Low/High 2600.00
2785.00
YEAR Low/High 2600.00
3850.00
All TIME Low/High 25.75
3850.00

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard